Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Cardinal raised FY2027 adjusted EPS guidance after strong fiscal Q1 earnings growth; shares gained 15.5% through November 10 and reached a new 12-month high.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Strong cash flow ⢠Thin profitability ⢠Weak liquidity CAH delivers strong cash flow and manageable leverage, but thin margins, negative equity, and weak liquidity warrant caution despite a low sales multiple.
Price Behavior
Key Price Behavior Insights: ⢠Downtrend intact ⢠Support test ⢠Rebound threshold Support Level: $225â226 Resistance Level: $232â235 CAH is in a bearish last-month downtrend, with $225â226 support at risk; reclaiming $232â235 would signal easing pressure.
Sentiment & News
Key News Insights: ⢠Growth Momentum ⢠Institutional Buying ⢠Margin Risks Cardinal Health's growth drivers and institutional backing support a constructive outlook, though pricing, cost, and capital-spending risks warrant monitoring amid recent share weakness.
AI Summary
CAH is now a cash-generative healthcare-services and specialty-growth story rather than a pure distributor, but at ~33x earnings investors should require proof that post-refund, post-tax-item operating growth and free cash flow remain strong as Specialty normalizes and acquisitions integrate.
Description
Cardinal Health, Inc. is a global healthcare services and products company that supplies hospitals, pharmacies, clinics, laboratories and patients at home. It operates two reporting segments: Pharmaceutical distribution and services for branded, generic and specialty drugs, and Medical, which manufactures and distributes a broad range of medical, surgical and laboratory supplies while providing supply-chain and kit assembly services to care providers. The company was founded in 1979 and is headquartered in Dublin, Ohio.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Nov 11 | Nov 18 | CAH | Cardinal Health, Inc. | Cardinal raised FY2027 adjusted EPS guidance after strong fiscal Q1 earnings growth; shares gained 15.5% through November 10 and reached a new 12-month high. | Closed | +0.3% |